RxDoctor Payments Data

Huey McDaniel, MD

Vascular Surgery · Pensacola, FLNPI 1710905807

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $21,406 of the $35,031 with a category attached, or 61.1%. 34 manufacturers reported payments, led by Silk Road Medical, Inc. at 39.4% of the total. Reporting peaked in 2021 at $14,448 and has fallen 65.6% since, to $4,974 in 2025.

$35,031in general payments, 2019–2025

Across 256 payments — averaging $136.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Silk Road Medical, Inc.$14K
  • Endologix LLC$4K
  • W. L. Gore & Associates, Inc.$3K
  • Penumbra, Inc.$3K
  • Bolton Medical Inc$2K
  • Angiodynamics, Inc.$2K
  • plus $8K from 28 others
$52,791in research payments, 2019–2025

Across 13 payments — averaging $4060.87 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Endologix LLC$29K
  • Cardiovascular Systems Inc.$14K
  • Trireme Medical LLC$10K

What the payments were for

  • Consulting fees$8,85025%
  • Travel & lodging$4,77514%
  • Food & beverage$21,40661%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$35,031 in reported general payments places this provider in the 85th percentile of 385 vascular surgery providers in Florida.

See all vascular surgery providers in Florida

Medicare billing

Part B allowed, 2024
$228,038
Medicare patients
201
Services billed
613

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban12$6,835
ClopidogrelClopidogrel Bisulfate24$194
Atorvastatin Calcium25$121
Cilostazol17$109

Paid to pharmacies, not to this prescriber.

Other vascular surgery in Pensacola

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →